Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies that bind human CD39 and inhibit ATPase activity of a soluble extracellular domain human CD39 polypeptide

Antibodies that bind human CD39 and inhibit ATPase activity of a soluble extracellular domain human CD39 polypeptide

US Patent 11377503 · Granted Jul 5, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of T cell lymphoma2025
NKp46 binding agents2025
NKp46 binding agents2025
Multispecific NK engager protein2025
Multispecific NK engager protein2025
Humanized antibodies with increased stability2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025